Verification Opinion of CITIC Securities Co., Ltd. on the Storage and Use of Funds Raised by Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. for 2025
CITIC Securities Co., Ltd. (hereinafter referred to as "CITIC Securities" or "Sponsor") has acted as the sponsor for the initial public offering and continuous supervision of Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. (hereinafter referred to as "Jianfa Zhixin" or "Company"). In accordance with relevant regulations including the "Administrative Measures for Sponsoring Securities Issuance and Listing," "Shenzhen Stock Exchange GEM Listing Rules," and "Self-Regulatory Guidelines No. 2 for Listed Companies on the Shenzhen Stock Exchange - Standardized Operations of GEM Listed Companies," CITIC Securities conducted a special verification of the storage and use of the funds raised by Jianfa Zhixin for 2025. The verification results are as follows:
1. Basic Situation of the Raised Funds
(1) Actual Amount of Funds Raised and Timing of Fund Arrival
With the approval of the China Securities Regulatory Commission (CSRC) document [2025] No. 1337 regarding the registration of the initial public offering of shares by Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd., the lead underwriter CITIC Securities Co., Ltd. publicly issued 63,193,277 shares of RMB ordinary shares at an issue price of RMB 7.05 per share. As of September 22, 2025, the company has publicly issued 63,193,277 shares, raising a total of RMB 445,512,602.85. After deducting total issuance costs of RMB 82,178,138.53 (excluding VAT), the actual net amount raised was RMB 363,334,464.32. The arrival of the funds has been verified by Rongcheng Accounting Firm (Special General Partnership) verification report [2025] No. 361Z0047. The company has adopted a special account storage system for the raised funds.
(2) Use and Balance of the Raised Funds
In 2025, the company directly invested RMB 181,390,800 in projects funded by the raised funds. As of December 31, 2025, the usage of the raised funds is as follows:
| Item | Amount (RMB 10,000) | Remarks |
|---|---|---|
| Net amount of raised funds | 36,333.45 | |
| Plus: Cumulative interest income from raised funds (after deducting fees) | 10.77 | |
| Less: Cumulative use of raised funds | 18,139.08 | |
| - Of which: Directly invested funds in funded projects | 18,139.08 | |
| Balance of raised funds (4=1+2-3) | 18,205.14 | Note: The difference of RMB 31,379,000 between the balance of raised funds and the balance in the special account is all issuance costs, of which RMB 25,788,200 are issuance costs that have completed the replacement approval process but have not yet been transferred from the special account, and RMB 5,590,900 are unpaid issuance costs. |